Big Gain For I-Mab

Mon, Apr 14, 2025 at 07:55 PM
Big Gain For I-Mab

I-Mab (IMAB:NASDAQ) shot up at $0.96, a gain of 43%. On Mon, Apr 14, 2025, IMAB:NASDAQ touched a New 2-Week High of $0.96. The stock appeared on our News Catalysts scanner on Thu, Apr 03, 2025 at 06:43 PM in the 'INVESTOR UPDATE' category. From Mon, Mar 31, 2025, the stock recorded 20.00% Up Days and 45.45% Green Days

About I-Mab (IMAB:NASDAQ)

I-MAB is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company's product pipeline includes TJ202, TJ301, TJ107, TJC4, TJD5, and TJM2.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.